Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy
2017
Il coinvolgimento cardiaco nella malattia di Anderson-Fabry: nuove raccomandazioni sulla diagnosi, il follow-up e la terapia
2015
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
2014
Uncertain diagnosis of Fabry disease: Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance
2014
Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
2013
Anderson-Fabry, the histrionic disease: from genetics to clinical management
2013
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson–Fabry disease
2012
Recommendations on Reintroduction of Agalsidase Beta for Patients with Fabry Disease in Europe, Following a Period of Shortage
2011
La malattia di Anderson-Fabry
2011
Distal Extremity Pain as a Presenting Feature of Fabry’s Disease
2011
Cardiovascular Events in Patients With Fabry Disease
2005
Hypertrophic cardiomyopathy in the community: why we should care
2004
New Concepts in Hypertrophic Cardiomyopathies
2003
Maximum Left Ventricular Thickness and Risk of Sudden Death Primary Myocardial Disease in Patients With Hypertrophic Cardiomyopathy
2005
Hypertrophic cardiomyopathy in the community: why we should care
2004
New Concepts in Hypertrophic Cardiomyopathies
2003
Maximum Left Ventricular Thickness and Risk of Sudden Death Primary Myocardial Disease in Patients With Hypertrophic Cardiomyopathy